Could a drug given to dogs to treat cancer fight Covid?
Research by experts at the University of Chicago showed masitinib worked just as well against variants, and other similar viruses that can make humans ill. (Source: the Mail online | Health)
Source: the Mail online | Health - July 22, 2021 Category: Consumer Health News Source Type: news

At 98 and facing cancer, Bob Dole reckons with legacy of Trump and ponders future of GOP
"I'm a Trumper," said Dole, the only former GOP presidential nominee to attend Trump's convention in 2016. But he added, "I'm sort of... (Source: Reuters: Health)
Source: Reuters: Health - July 22, 2021 Category: Consumer Health News Source Type: news

Antibiotics may help to treat melanoma
Some antibiotics appear to be effective against a form of skin cancer known as melanoma. Researchers at KU Leuven, Belgium, examined the effect of these antibiotics on patient-derived tumours in mice. Their findings were published in the Journal of Experimental Medicine. (Source: World Pharma News)
Source: World Pharma News - July 22, 2021 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Annual mammography catches more interval cancer in dense breasts
Areas in Canada that offered annual mammography screening to women with dens...Read more on AuntMinnie.comRelated Reading: Breast MRI useful in detecting early interval cancers High BMI linked to higher risk of interval breast cancer DBT shows promise in new study with lower interval cancer rates Density notification laws are working -- but not equally AI catches interval breast cancers missed by rads (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 22, 2021 Category: Radiology Source Type: news

Advanced bladder cancers respond to immunotherapy regardless of gene mutation status
(UNC Lineberger Comprehensive Cancer Center) UNC Lineberger researchers and colleagues report a study has demonstrated that patients with advanced bladder cancers whose tumors have a mutated FGFR3 gene respond to immunotherapy in a manner that is similar to patients without that mutation. This discovery runs counter to previous research that suggested FGFR3-mutated bladder cancers should not be treated with immunotherapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 22, 2021 Category: Cancer & Oncology Source Type: news

Mayo Clinic research suggests women over 65 be offered hereditary cancer genetic testing
(Mayo Clinic) A new study by Fergus Couch, Ph.D., of Mayo Clinic Cancer Center, along with collaborators from the CARRIERS consortium, suggests that most women with breast cancer diagnosed over 65 should be offered hereditary cancer genetic testing. The study was published Thursday, July 22, in the Journal of Clinical Oncology. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 22, 2021 Category: Cancer & Oncology Source Type: news

Study on chromosomal rearrangements in yeast reveals potential avenue for cancer therapy
(Osaka University) Researchers from Osaka University have found that the attachment of a ubiquitin molecule to a protein called PCNA at the lysine 107 position causes gross chromosomal rearrangements. This lysine is located where two PCNA molecules interact, and the ubiquitin attachment to it may change the ring structure they form. The ubiquitin attachment occurs through the action of Rad8 (a ubiquitin ligase) and Mms2-Ubc4 (a ubiquitin conjugating enzyme). This implies that inhibiting the human equivalent of this ubiquitination could prevent cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 22, 2021 Category: Cancer & Oncology Source Type: news

Geneticists reveal how mutation causes childhood cancer; use drug to reverse its effects
(Trinity College Dublin) Geneticists from Trinity College Dublin have discovered how a specific genetic mutation (H3K27M) causes a devastating, incurable childhood cancer, known as diffuse midline glioma (DMG), and - in lab studies working with model cell types - successfully reverse its effects to slow cancer cell growth with a targeted drug. Their landmark work - just published in leading international journal, Nature Genetics - translates crucial new understanding of the genetics of DMG progression into a highly promising, targeted therapeutic approach and offers significant hope of improved treatments in the future. (S...
Source: EurekAlert! - Cancer - July 22, 2021 Category: Cancer & Oncology Source Type: news

Studies find combination chemotherapy beneficial and cost-effective in sub-Saharan Africa
(UNC Lineberger Comprehensive Cancer Center) Researchers at the UNC Lineberger Comprehensive Cancer Center demonstrated in a clinical trial in Malawi that a five-drug combination chemotherapy provided curative benefit compared to current standard-of care-therapy in people diagnosed with lymphoma, and now they have determined this option is also cost-effective. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 22, 2021 Category: Cancer & Oncology Source Type: news

New study provides clues to decades-old mystery about cell movement
(University of Minnesota) A new study, led by University of Minnesota Twin Cities engineering researchers, shows that the stiffness of protein fibers in tissues, like collagen, are a key component in controlling the movement of cells. The groundbreaking discovery provides the first proof of a theory from the early 1980s and could have a major impact on fields that study cell movement from regenerative medicine to cancer research. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - July 22, 2021 Category: Biology Source Type: news

Cardio-cerebrovascular disease history complicates hematopoietic cell transplant outcomes
(Cactus Communications) Transplanting hematopoietic stem cells to treat cancers and other conditions carries with it the risk of developing cardio-cerebrovascular diseases (CCVD)--disorders affecting the blood vessels of the heart and brain. Although research on post-transplant CCVD is extensive, there is paucity of knowledge on the effects of pre-transplant CCVD on transplant outcomes. Now researchers in China suggest pre-transplant CCVD indirectly affects patient mortality and survival following transplant through their strong association with post-transplant CCVD. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 22, 2021 Category: International Medicine & Public Health Source Type: news

Artificial intelligence models to analyze cancer images take shortcuts that introduce bias
(University of Chicago Medical Center) A new study led by researchers from the University of Chicago shows that deep learning models trained on large sets of cancer genetic and tissue histology data can easily identify the institution that submitted the images. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 22, 2021 Category: International Medicine & Public Health Source Type: news

Rensselaer-designed platform could enable personalized immunotherapy
(Rensselaer Polytechnic Institute) An innovative testing platform that more closely mimics what cancer encounters in the body may allow for more precise, personalized therapies by enabling the rapid study of multiple therapeutic combinations against tumor cells. The platform, which uses a three-dimensional environment to more closely mirror a tumor microenvironment, is demonstrated in research published in Communications Biology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 22, 2021 Category: International Medicine & Public Health Source Type: news

Prostate cancer treatment among black, white patients during pandemic
This study included 647 patients with untreated nonmetastatic prostate cancer (269 patients during the pandemic and 378 from before the pandemic). During the initial COVID-19 lockdown, only 1% of Black men underwent prostatectomy, while 26% of white patients did. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 22, 2021 Category: Infectious Diseases Source Type: news

Bidirectional impact of cardiovascular disease, cancer in Blacks focus of new AHA center
(Medical College of Georgia at Augusta University) Cardiovascular disease and cancer, the nation's top two killers, share common ground like obesity and chronic inflammation, as well as a disproportionate impact on Black Americans. A new American Heart Association-funded center at the Medical College of Georgia is working to better understand the bidirectional dynamic, including how to intervene when, for example, cancer treatment itself results in heart problems. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 22, 2021 Category: International Medicine & Public Health Source Type: news

Antibiotics may help to treat melanoma
(KU Leuven) Some antibiotics appear to be effective against a form of skin cancer known as melanoma. Researchers at KU Leuven, Belgium, examined the effect of these antibiotics on patient-derived tumours in mice. Their findings were published in the Journal of Experimental Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 22, 2021 Category: International Medicine & Public Health Source Type: news

Study shows cancer misinformation common on social media sites
(Huntsman Cancer Institute) A new study published online today in the Journal of the National Cancer Institute reports that one third of the most popular cancer treatment articles on social media contain misinformation. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 22, 2021 Category: International Medicine & Public Health Source Type: news

FDA Approves Keytruda (pembrolizumab) Plus Lenvima (lenvatinib) Combination for Patients With Certain Types of Advanced Endometrial Carcinoma
KENILWORTH& WOODCLIFF, N.J.--(BUSINESS WIRE) July 22, 2021 -- Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Eisai Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the combination of... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - July 22, 2021 Category: Drugs & Pharmacology Source Type: news

Pfizer Expands Recall of Smoking Cessation Drug Chantix Pfizer Expands Recall of Smoking Cessation Drug Chantix
The FDA says the health benefits of stopping smoking outweigh the cancer risk from the nitrosamine impurity potentially contained in the recalled varenicline lots.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 22, 2021 Category: Cancer & Oncology Tags: Psychiatry News Source Type: news

Mayo Clinic research suggests women over 65 be offered hereditary cancer genetic testing
ROCHESTER, Minn. — A new study by Fergus Couch, Ph.D., of Mayo Clinic Cancer Center, along with collaborators from the CARRIERS consortium, suggests that most women with breast cancer diagnosed over 65 should be offered hereditary cancer genetic testing. The study was published Thursday, July 22, in the Journal of Clinical Oncology. Dr. Couch says that women over 65 rarely qualify for hereditary cancer genetic testing based on current testing guidelines because they are thought… (Source: Mayo Clinic Minnesota News)
Source: Mayo Clinic Minnesota News - July 22, 2021 Category: Hospital Management Source Type: news

ASCO 2021: Best Lung Cancer IO Data ASCO 2021: Best Lung Cancer IO Data
Pooled analysis supports chemo + immunotherapy for patients with PD-L1 1%-49%; immunosuppressants for adverse effects of immunotherapy; and AI predicts outcomes better than pathologic exam.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 21, 2021 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

Risk for Psoriasis Increased for Cancer Survivors
Increased risks seen for survivors of leukemia, lymphoma, multiple myeloma, skin cancer, and lung cancer in subgroup analyses (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - July 21, 2021 Category: Cancer & Oncology Tags: Dermatology, Internal Medicine, Oncology, Journal, Source Type: news

Lifesaving help needed for Venezuela cancer patients hit by US sanctions
Independent UN rights experts on Wednesday warned that hundreds of Venezuelan cancer patients could die because they have been caught up in the excessively strict application of United States sanctions aimed at Venezuela and the state-owned oil company, Petroleum of Venezuela. (Source: UN News Centre - Health, Poverty, Food Security)
Source: UN News Centre - Health, Poverty, Food Security - July 21, 2021 Category: International Medicine & Public Health Source Type: news

Protecting Medicare from government interference
For more than a decade,Medicare Part D has provided seniors and people with disabilities with affordable and comprehensive prescription medicine coverage. Several surveys show that more than 9 in 10 Part D enrollees are satisfied with their coverage, helping tens of millions of patients manage a number of chronic and life-threatening conditions, including diabetes, mental illness, cancer and heart disease. (Source: The Catalyst)
Source: The Catalyst - July 21, 2021 Category: Pharmaceuticals Authors: Gabby Migliara Tags: Part D Medicare Proactive Agenda Source Type: news

Ovarian cysts symptoms: Are ovarian cysts always cancerous?
OVARIAN cysts are fluid-filled sacs that develop on an ovary and don't normally cause any symptoms. So how do you know if you've got one, and are ovarian cysts always cancerous? (Source: Daily Express - Health)
Source: Daily Express - Health - July 21, 2021 Category: Consumer Health News Source Type: news

Lung cancer: The peculiar warning sign found on your fingers or nails indicating your risk
LUNG cancer does not produce any obvious symptoms in the early stages. A change in the size of your fingers could be a major symptom, however, warning it may be the deadly disease. (Source: Daily Express - Health)
Source: Daily Express - Health - July 21, 2021 Category: Consumer Health News Source Type: news

Cancer Researchers Use Astronomy Analysis Algorithms to Develop Platform for Locating and Examining Predictive Biomarkers in Tumors
Yet another example that technologies from non-medical fields continue to find their way into anatomic pathology and clinical laboratory medicine Anatomic pathologists and medical laboratory scientists may soon have new tools in the fight against cancer, thanks to researchers at the Mark Foundation Center for Advanced Genomics and Imaging at Johns Hopkins University and Bloomberg-Kimmel […] The post Cancer Researchers Use Astronomy Analysis Algorithms to Develop Platform for Locating and Examining Predictive Biomarkers in Tumors appeared first on Dark Daily. (Source: Dark Daily)
Source: Dark Daily - July 21, 2021 Category: Laboratory Medicine Authors: Jillia Schlingman Tags: Clinical Laboratory/Pathology Automation, Analyzers, Testing Systems Digital Pathology Instruments & Equipment Laboratory News Laboratory Pathology Laboratory Testing Precision Medicine Alexander S. Szalay PhD anatomic pathology Anti-PD- Source Type: news

Attitudes towards and experiences of the NHS during Covid-19: views from patients, professionals and the public
This report is the third and final report from a collaboration with Britain Thinks to understand how the experiences and perceptions of patients, professionals and the public have shifted during the pandemic and what this might mean for the future of the NHS in England. It looks at the NHS across three areas: primary care; secondary care; and community care. It also examines four patient types: mental health; long term health conditions; cancer patients; and surgery patients. Additionally, it looks into what patients and the public understand about the term'health inequalities'.ReportThe Richmond Group of Charities...
Source: The Kings Fund - Health Management Specialist Collection - July 21, 2021 Category: Health Management Authors: The King ' s Fund Library Tags: Covid-19 Patient involvement, experience and feedback Workforce and employment Source Type: news

Risk for Psoriasis Increased for Cancer Survivors
WEDNESDAY, July 21, 2021 -- Cancer survivors, especially survivors of hematologic malignancies, have an increased risk for psoriasis, according to a research letter published online June 30 in the British Journal of Dermatology. Miri Kim, M.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 21, 2021 Category: Pharmaceuticals Source Type: news

Covid may have been in Italy as early as October 2019, experts find
Blood samples taken from a cancer patient contained coronavirus antibodies, two months before China reported the virus, researchers in Italy and the Netherlands have found. (Source: the Mail online | Health)
Source: the Mail online | Health - July 21, 2021 Category: Consumer Health News Source Type: news

Lack of After Care Leaves Cancer Patients in'Survivorship Abyss'Lack of After Care Leaves Cancer Patients in'Survivorship Abyss '
Ten years after being diagnosed with prostate cancer, 98% of men are still alive – but many report ongoing adverse effects that make life a struggle.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - July 21, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

New Drug Combination Shows Promise for Peritoneal Mesothelioma
Researchers at MD Anderson Cancer Center in Houston have uncovered a new, promising treatment option for patients with peritoneal mesothelioma, potentially filling a gaping void that exists today. The immunotherapy drug combination of Tecentriq and Avastin, known generically as atezolizumab and bevacizumab, respectively, showed unusual efficacy in a recent study of 20 patients with this rare cancer. Although some patients have previously found significant success and extended survival with the cytoreductive surgery and hyperthermic intraperitoneal chemotherapy combination, or HIPEC, those with unresectable disease ha...
Source: Asbestos and Mesothelioma News - July 21, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news

Johnson & Johnson Reports Q2 2021 Results
New Brunswick, N.J. (July 21, 2021) – Johnson & Johnson (NYSE: JNJ) today announced results for second-quarter. “Our second-quarter results showcase Johnson & Johnson’s diversified portfolio, driven by strong sales and earnings growth across our Medical Device, Consumer Health and Pharmaceutical businesses,” said Alex Gorsky, Chairman and Chief Executive Officer. “I’m so proud of our 136,000 colleagues who remain focused on delivering our medicines and products to patients and consumers around the world, in addition to advancing our pipeline with new product launches and regulato...
Source: Johnson and Johnson - July 21, 2021 Category: Pharmaceuticals Tags: Our Company Source Type: news

Namibia: Boot Out Cancer, Wear Your Funky Shoelaces, Socks and Ribbons
[Namibia Economist] The Cancer Association of Namibia (CAN) is selling funky shoelaces, socks and ribbons for their initiative 'Boot out Cancer', to help pay it forward through their patient support programmes. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - July 21, 2021 Category: African Health Source Type: news

COVID-19 Caused U.S. Life Expectancy to Drop 1.5 Years
Life expectancy in the United States dropped the most in more than seven decades last year as Covid-19 sent hundreds of thousands of Americans to early deaths. The pandemic’s disproportionate toll on communities of color also widened existing gaps in life expectancy between White and Black Americans, according to estimates released by the Centers for Disease Control and Prevention. The tally represents an extraordinarily grim accounting of an ongoing catastrophe. The first year of the pandemic delivered a bigger blow to American life expectancy than any year of the Vietnam War, the AIDS crisis or the “deaths of...
Source: TIME: Health - July 21, 2021 Category: Consumer Health News Authors: John Tozzi / Bloomberg Tags: Uncategorized COVID-19 overnight wire Source Type: news

Novartis aims to beat rivals to novel $10bn cancer treatment market
Trial results for new targeted therapy ‘pretty remarkable’, says CEO (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - July 21, 2021 Category: Pharmaceuticals Source Type: news

Is There a Screening Test for Lung Cancer?
Title: Is There a Screening Test for Lung Cancer?Category: Diseases and ConditionsCreated: 7/21/2021 12:00:00 AMLast Editorial Review: 7/21/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - July 21, 2021 Category: Cancer & Oncology Source Type: news

Glandular tissue on ultrasound associated with breast cancer risk
Glandular tissue is associated with future breast cancer risk in women wit...Read more on AuntMinnie.comRelated Reading: Researchers tout algorithm in classifying breast tissues Routine screening for BI-RADS 3 lesions means lower recall rates AI detects axillary lymph node metastasis on multiparametric MRI COVID screening delays may lead to more breast cancer deaths Inpatient mammography feasible for women overdue for screening (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 21, 2021 Category: Radiology Source Type: news

CMS changes to RO Model draw ASTRO's ire
A proposal by the U.S. Centers for Medicare and Medicaid Services (CMS) to mak...Read more on AuntMinnie.comRelated Reading: ASTRO commits to October in-person annual meeting in Chicago ASTRO survey finds rise in advanced-stage cancer ASTRO lauds Biden's CMS administrator nomination CMS to delay start of RO Model for radiation therapy CMS releases new payment model for radiation oncology (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 21, 2021 Category: Radiology Source Type: news

FDA grants Breakthrough Therapy Designation for Venclexta in combination with azacitidine for the treatment of patients with myelodysplastic syndromes
Basel, 21 July 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that Venclexta ® (venetoclax) in combination with azacitidine has been granted Breakthrough Therapy Designation (BTD) by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with previously untreated intermediate, high- and very high-risk myelodysplastic syndromes (MDS) based on the rev ised International Prognostic Scoring System (IPSS-R). MDS are a rare group of blood cancers that gradually affect the ability of the bone marrow to produce normal blood cells.2 This can lead to weakness, frequent infections, anaemia and ...
Source: Roche Investor Update - July 21, 2021 Category: Pharmaceuticals Source Type: news

FDA grants Breakthrough Therapy Designation for Venclexta in combination with azacitidine for the treatment of patients with myelodysplastic syndromes
Basel, 21 July 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that Venclexta ® (venetoclax) in combination with azacitidine has been granted Breakthrough Therapy Designation (BTD) by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with previously untreated intermediate, high- and very high-risk myelodysplastic syndromes (MDS) based on the rev ised International Prognostic Scoring System (IPSS-R). MDS are a rare group of blood cancers that gradually affect the ability of the bone marrow to produce normal blood cells.2 This can lead to weakness, frequent infections, anaemia and ...
Source: Roche Media News - July 21, 2021 Category: Pharmaceuticals Source Type: news

Scientists provide new insight on how to stop transcription of cancer cells
(University of California - Los Angeles Health Sciences) Findings could help pave the way for cancer therapies that target TAF12, potentially stopping transcription in cancer cells and helping decrease the growth of cancerous tumors. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 21, 2021 Category: Cancer & Oncology Source Type: news

New approach eradicates breast cancer in mice
(University of Illinois at Urbana-Champaign, News Bureau) A new approach to treating breast cancer kills 95-100% of cancer cells in mouse models of human estrogen-receptor-positive breast cancers and their metastases in bone, brain, liver and lungs. The newly developed drug, called ErSO, quickly shrinks even large tumors to undetectable levels. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 21, 2021 Category: Cancer & Oncology Source Type: news

Study: Ibrutinib effective treatment for difficult to treat forms of hairy cell leukemia
(Ohio State University Wexner Medical Center) The oral targeted therapy drug ibrutinib is an effective treatment option for high-risk hairy cell leukemia, according to a new study conducted by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 21, 2021 Category: Cancer & Oncology Source Type: news

Lehigh University team aims to reduce American Indian smokeless tobacco use
(Lehigh University) The Lehigh University College of Health Institute for Indigenous Studies has been awarded nearly $1.8 million from the American Cancer Society. The grant will support the researchers as they test the efficacy of a culturally tailored program aimed at reducing American Indian smokeless tobacco use. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 21, 2021 Category: International Medicine & Public Health Source Type: news

Scientists link frailty and neurocognitive decline in childhood cancer survivors
(St. Jude Children's Research Hospital) St. Jude Children's Research Hospital scientists have shown that frailty contributes to neurocognitive decline in young adult survivors of childhood cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 21, 2021 Category: International Medicine & Public Health Source Type: news

Cancer: Information theory to fight resistance to treatments
(Universit é de Gen è ve) A major challenge in cancer therapy is the adaptive response of cancer cells to targeted therapies. Although this adaptive response is theoretically reversible, such a reversal is hampered by numerous molecular mechanisms that allow the cancer cells to adapt to the treatment. A team (UNIGE/HUG) has used information theory, in order to objectify in vivo the molecular regulations at play in the mechanisms of the adaptive response and their modulation by a therapeutic combination. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 21, 2021 Category: International Medicine & Public Health Source Type: news

Cell couriers deliver clue to cancer metastasis
(University of Warwick) A protein involved in making cells move offers a clue to how certain types of cancer metastasize and develop into secondary tumours, according to new research from the University of Warwick. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 21, 2021 Category: International Medicine & Public Health Source Type: news

Hundreds of chemicals, many in consumer products, could increase breast cancer risk
(Silent Spring Institute) a new study shows that several hundred common chemicals, including pesticides, ingredients in consumer products, food additives, and drinking water contaminants, could increase the risk of breast cancer by causing cells in breast tissue to produce more of the hormones estrogen or progesterone. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 21, 2021 Category: Cancer & Oncology Source Type: news

Scientists identify protein markers related to the most common form of leukemia
(Wiley) Chronic lymphocytic leukemia (CLL) is the most common leukemia in the Western world. New research published in the Journal of Leukocyte Biology reveals that certain protein markers may indicate which patients have stable forms of CLL and which have more aggressive types. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 21, 2021 Category: Cancer & Oncology Source Type: news